Lam WS

No ORCID on file · 3 papers in corpus
2025
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial.
JAMA oncology ·doi:10.1001/jamaoncol.2025.1916

ImportanceGynecological clear cell cancers (CCCs) are aggressive malignant neoplasms with low response rate to chemotherapy. The treatment of patients with metastatic disease remains an area of significant unmet need.ObjectiveTo evaluate th…

2016
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd001750.pub4

BackgroundGonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-oestrogenic side-effects, flare-up, or long down-regulati…

2016
Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd003719.pub4

BackgroundFor the last few decades urinary human chorionic gonadotrophin (uhCG) has been used to trigger final oocyte maturation in cycles of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Recombinant technology h…